Match placebo to test product
Sponsors
Sanofi-Aventis Recherche & Developpement
Conditions
Crohn's diseasePsoriasisRheumatoid arthritis
Phase 2
A Phase 2, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging study of Efficacy and Safety of SAR441566 in Adults with Moderate to Severe Plaque Psoriasis
CompletedCTIS2023-503911-14-00
Start: 2024-01-25End: 2024-11-20Target: 242Updated: 2024-12-09
A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-ranging, Efficacy and Safety study of SAR441566 plus Methotrexate in Adults with Moderate to Severe Rheumatoid Arthritis
CompletedCTIS2023-503910-60-00
Start: 2024-03-05End: 2025-07-02Target: 194Updated: 2025-08-19
A Phase 2, multinational, multicenter, randomized, double blind, placebo controlled, dose-ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate to severe Crohn’s disease.
RecruitingCTIS2024-512633-32-00
Start: 2025-04-07Target: 169Updated: 2026-01-09